Citadel Advisors’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $2.06M | Sell |
|
|||||
|
2019
Q4 | $37.2M | Buy |
|
|||||
|
2019
Q3 | $2.62M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $7.61M | Sell |
|
|||||
|
2018
Q4 | $19.8M | Buy |
|
|||||
|
2018
Q3 | $5.95M | Sell |
|
|||||
|
2018
Q2 | $3.48M | Buy |
|
|||||
|
2018
Q1 | $1.75M | Buy |
|
|||||
|
2017
Q4 | $2.54M | Sell |
|
|||||
|
2017
Q3 | $4.66M | Buy |
|